Chenglu Jiang
Overview
Explore the profile of Chenglu Jiang including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
20
Citations
176
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Wang G, Huang J, Chen H, Jiang C, Jiang L, Feng W, et al.
Discov Oncol
. 2025 Mar;
16(1):311.
PMID: 40080320
Background: Kidney renal clear cell carcinoma (KIRC) constitutes the primary subtype of renal cell carcinoma, representing 75% to 80% of cases and carrying a substantial cancer-specific mortality rate of up...
2.
Chen H, Lai H, Chi H, Fan W, Huang J, Zhang S, et al.
Front Cardiovasc Med
. 2024 Dec;
11:1397407.
PMID: 39660117
Background: Atherosclerosis, a complex chronic vascular disorder with multifactorial etiology, stands as the primary culprit behind consequential cardiovascular events, imposing a substantial societal and economic burden. Nevertheless, our current understanding...
3.
Jiang L, Zhang S, Jiang C, Chen H, Huang J, Yang J, et al.
Sci Rep
. 2024 Oct;
14(1):24290.
PMID: 39414957
Background We aimed to pinpoint biomarkers, create a diagnostic model for ulcerative colitis (UC), and delve into its immune features to better understand this autoimmune condition. Methods The sequencing data...
4.
Gu Y, Jiang L, Shui M, Luo H, Zhou X, Zhang S, et al.
Front Cell Infect Microbiol
. 2024 Oct;
14:1452392.
PMID: 39355266
Background: Colorectal cancer (CRC) poses a global health threat, with the oral microbiome increasingly implicated in its pathogenesis. This study leverages Mendelian Randomization (MR) to explore causal links between oral...
5.
Jiang L, Liu J, Zhang S, Jiang C, Huang J, Chen H, et al.
Front Immunol
. 2024 Aug;
15:1438935.
PMID: 39156890
Background: pancreatic ductal adenocarcinoma (PDAC) is a malignant tumor with a very poor prognosis and a complex tumor microenvironment, which plays a key role in tumor progression and treatment resistance....
6.
Yan M, Zhang J, Wang C, Gao L, Liu W, Zhang J, et al.
J Colloid Interface Sci
. 2024 Aug;
677(Pt A):1069-1079.
PMID: 39137609
Designing inexpensive, high-efficiency and durable bifunctional catalysts for urea oxidation reaction (UOR) and hydrogen evolution reaction (HER) is an encouraging tactic to produce hydrogen with reduced energy expenditure. Herein, oxygen...
7.
Chen H, Zuo H, Huang J, Liu J, Jiang L, Jiang C, et al.
J Cell Mol Med
. 2024 Jul;
28(12):e18403.
PMID: 39031800
Kidney renal clear cell carcinoma (KIRC) pathogenesis intricately involves immune system dynamics, particularly the role of T cells within the tumour microenvironment. Through a multifaceted approach encompassing single-cell RNA sequencing,...
8.
Tu H, Hu Q, Ma Y, Huang J, Luo H, Jiang L, et al.
J Cell Mol Med
. 2024 Jul;
28(13):e18524.
PMID: 39011666
Clear cell renal cell carcinoma (ccRCC), a prevalent kidney cancer form characterised by its invasiveness and heterogeneity, presents challenges in late-stage prognosis and treatment outcomes. Programmed cell death mechanisms, crucial...
9.
Jiang L, Ren X, Yang J, Chen H, Zhang S, Zhou X, et al.
Front Immunol
. 2024 Jul;
15:1400431.
PMID: 38994370
Background: Clear Cell Renal Cell Carcinoma (ccRCC) is the most common type of kidney cancer, characterized by high heterogeneity and complexity. Recent studies have identified mitochondrial defects and autophagy as...
10.
Tang J, Zhang S, Jiang L, Liu J, Xu J, Jiang C, et al.
J Cancer
. 2024 Jul;
15(13):4219-4231.
PMID: 38947379
Hepatocellular carcinoma (HCC), the predominant malignancy of the digestive tract, ranks as the third most common cause of cancer-related mortality globally, significantly impeding human health and lifespan. Emerging immunotherapeutic approaches...